about
The potential for improvement of outcomes by personalized insulin treatment of type 1 diabetes as assessed by analysis of single-patient data from a randomized controlled cross-over insulin trial.Varenicline may trigger severe hypoglycaemia in Type 1 diabetes.A prospective randomised cross-over study of the effect of insulin analogues and human insulin on the frequency of severe hypoglycaemia in patients with type 1 diabetes and recurrent hypoglycaemia (the HypoAna trial): study rationale and design.Testing the validity of the Danish urban myth that alcohol can be absorbed through feet: open labelled self experimental study.Influence of erythropoietin on cognitive performance during experimental hypoglycemia in patients with type 1 diabetes mellitus: a randomized cross-over trialImpact of the TCF7L2 genotype on risk of hypoglycaemia and glucagon secretion during hypoglycaemia.Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trial.Short-term cost-effectiveness of insulin detemir and insulin aspart in people with type 1 diabetes who are prone to recurrent severe hypoglycemia.Effect of insulin analogues on frequency of non-severe hypoglycaemia in patients with type 1 diabetes prone to severe hypoglycaemia: The HypoAna trial.Glucose-dependent insulinotropic polypeptide augments glucagon responses to hypoglycemia in type 1 diabetes.NSAID-induced symptomatic hypophosphataemia.Cognitive performance, symptoms and counter-regulation during hypoglycaemia in patients with type 1 diabetes and high or low renin-angiotensin system activity.Nocturnal continuous glucose monitoring: accuracy and reliability of hypoglycemia detection in patients with type 1 diabetes at high risk of severe hypoglycemia.Vascular endothelial growth factor during hypoglycemia in patients with type 1 diabetes mellitus: relation to cognitive function and renin-angiotensin system activity.Erythropoietin during hypoglycaemia in type 1 diabetes: relation to basal renin-angiotensin system activity and cognitive function.Comparing effects of insulin analogues and human insulin on nocturnal glycaemia in hypoglycaemia-prone people with Type 1 diabetes.Obstructive sleep apnoea is frequent in patients with type 1 diabetes.Skin temperature measured by infrared thermography after specific ultrasound-guided blocking of the musculocutaneous, radial, ulnar, and median nerves in the upper extremity.Effect of Insulin Analogs on Frequency of Non-Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Severe Hypoglycemia: Much Higher Rates Detected by Continuous Glucose Monitoring than by Self-Monitoring of Blood Glucose-The HypoAna Trial.Glucocorticoid-induced diabetes in patients with metastatic spinal cord compression.The influence on survival of glucocorticoid induced diabetes in cancer patients with metastatic spinal cord compression.ACTH stimulation test in patients with type 1 diabetes and recurrent severe hypoglycaemia[Laymen's understanding of physicians' words. A study of understanding of commonly used medical terms][Spontaneous hemothorax from a fibrous pleural tumour in an expectant father. Is the delivery room a dangerous place for men?][Don't always rely on PACS: undetected loss of a central venous catheter guide wire]Insulin analogues and severe hypoglycaemia in type 1 diabetesImpact of Genetic Polymorphism in the β2-Receptor Gene on Risk of Severe Hypoglycemia in Patients With Type 1 DiabetesPhysical activity and type 1 diabetes: Moving from the laboratory to the real worldEarly incidence of glucocorticoid-induced diabetes in patients with brain tumors: a retrospective study of the first 7 days of treatmentOral Treatment of Glucocorticoid-Induced Diabetes Mellitus: A Systematic Review[Glucocorticoid-induced diabetes and risk factors during high-dose therapy]
P50
Q31151114-C185E0DD-1638-49D1-9FC2-57B7B8A9B9DFQ33439435-F4E00994-5CE8-424D-AE1C-2202514AFD6DQ34315270-3AFCD033-9AD0-4DCA-811B-06AEE02B4076Q34406372-90672829-A786-4CB4-B27A-C30CFB40D482Q34663582-EB201C7E-39F5-4B36-8AFE-0D66748BEAEAQ37396170-E681093C-FD8F-4F83-95D9-38F5A90E4E8DQ39198937-EA4D2E10-53D1-48CE-BF61-824EA0B2600DQ39667350-F91C0A0E-0073-4102-A2F9-BC5B62505B2BQ40805930-55763074-CBDE-4E00-86A1-7861CA4FD4DAQ42204919-654AB317-F331-40E7-A0FE-A4EDA3C66276Q42700875-392CAB87-110F-49BF-8B79-CE6138870B8DQ43283591-3FAD25A8-4D55-4723-9BB2-39E84764F9BCQ43847733-5E20B2F9-F9C9-4520-96BF-75886C96C340Q45941857-E6219793-016B-45C2-962D-140D02E33547Q46124885-3B893291-B93F-4C6C-A82B-65FD19054DAAQ47773370-C19F3BE4-1928-44DA-9EEC-4303ECF35CACQ47779827-78D9C6E9-2A37-4B04-B36D-D1539959885EQ48272841-481DC464-AA23-4506-8C51-4326EBB59463Q51736633-FD23FF96-F243-47B1-B44D-B911BBF9CD42Q52579770-AC697FD6-70EE-4B93-9F3F-F6832AAC9907Q55690351-0DAD8FC5-9216-433D-A68C-69E2AF64AE76Q59489136-E3726BE5-45D2-4AC6-A654-99B053D4D093Q75826380-A69A24AA-0063-4D58-97D2-E07117B5C239Q80166135-4E6CC563-B8E8-4279-8D67-69D7E271BE02Q81344254-71EBB769-83B0-467D-8FFF-FF10CBAA866DQ82782837-DF2E11FE-33C6-489D-A017-955E5D0B1A0FQ88661779-055C31B0-7323-4E71-860C-1A20C71AFF3DQ90899703-EA38A309-349E-4458-B903-FEA995683B64Q92445851-0DFFE24A-491E-48A7-AF59-F0F5A30DCB7CQ94553882-2A06CF58-D1C0-43FC-837E-81040DF7AD1EQ95529043-05F09C7B-4401-4ABE-B2A8-74BE5350568F
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Peter Lommer Kristensen
@ast
Peter Lommer Kristensen
@en
Peter Lommer Kristensen
@es
Peter Lommer Kristensen
@nl
Peter Lommer Kristensen
@sl
type
label
Peter Lommer Kristensen
@ast
Peter Lommer Kristensen
@en
Peter Lommer Kristensen
@es
Peter Lommer Kristensen
@nl
Peter Lommer Kristensen
@sl
prefLabel
Peter Lommer Kristensen
@ast
Peter Lommer Kristensen
@en
Peter Lommer Kristensen
@es
Peter Lommer Kristensen
@nl
Peter Lommer Kristensen
@sl
P106
P21
P31
P496
0000-0001-5431-824X